Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Omega Diagnostics launches VISITECT Covid-19 antigen test

Published 30/04/2021, 09:41
Updated 30/04/2021, 09:46
© Reuters

© Reuters

By Samuel Indyk

Investing.com – Medical diagnostics company Omega Diagnostics has today launched its VISITECT Covid-19 antigen test, a rapid test for the detection of active Covid-19 infections.

The launch of the product is in the final stage in the commercial rollout, after the product received CE marking last month.

The lateral flow test can give a visual read out in 10 minutes and can be used with throat and nasal swabs or just nasal only.

Accuracy

As previously announced by the firm, the test has a sensitivity of 98.4% on samples with a cycle threshold of

DHSC Contract Update

Omega has also provided an update on its Department of Health and Social Care (DHSC) contract where it will provide manufacturing capacity for licensed tests.

The AIM-listed company is still waiting for a decision from the DHSC on which tests have passed their performance evaluations and once a suitable test is approved, the DHSC will then license that test for Omega to manufacture. The value of the contract, announced in March, is up to £374mln.

“I am pleased to say that we are now producing a wide range of our own tests from our Alva site and we look forward to being notified which test we will produce under the UK Government contract, which will then see us move to production of up to two million tests a week,” said Omega Diagnostics (LON:ODX) CEO Colin King.

“In the meantime, there is much ongoing activity; not only are we producing our own tests, but we are also producing AbC-19 Rapid tests for the UK-RTC in anticipation of forthcoming orders as well as providing additional cassetting and pouching services to the UK Government for other COVID-19 antigen lateral flow tests.”

At 09:30BST, shares in Omega Diagnostics were trading lower by 2.2% at 71.92 pence per share.

Latest comments

this stock is going to be headed for massive gains soon.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.